Scienture Holdings, Inc. - Common Stock (SCNX)

Discover the top movers in Wednesday's pre-market session and stay informed about market dynamics.

Scienture's Q3 revenue surged on Arbli sales, debt dropped, and cash rose to $8 million ahead of its planned Rezenopy launch in early 2026.

Let's have a look at what is happening on the US markets on Tuesday. Below you can find the most active stocks in today's session.

Investors and traders are closely monitoring the gap up and gap down stocks in today's session on Tuesday. Let's explore the market movements and identify the stocks with significant gaps.

Scienture's Arbli losartan oral suspension gains access to over 100 million covered lives through national commercial and Medicare formularies.

Looking for insights into the US markets one hour before the close of the markets on Monday? Delve into the top gainers and losers of today's session and gain valuable market intelligence.

Let's have a look at what is happening on the US markets in the middle of the day on Monday. Below you can find the top gainers and losers in today's session.

Let's have a look at what is happening on the US markets one hour before the close of the markets on Friday. Below you can find the top gainers and losers in today's session.

Volume analysis on 2025-10-24: stocks with an unusual volume in today's session.

Keep an eye on the top gainers and losers in Friday's session, as they reflect the most notable price movements.

Let's delve into the US markets on Friday and uncover the stocks that are experiencing notable gaps in today's session. Below, you'll find the gap up and gap down stocks.

The US market is yet to commence its session on Friday, but let's get a preview of the pre-market session and explore the top gainers and losers driving the early market movements.